Search results
Top Studies From ESOC 2024 in Review
Medscape· 5 days agoMedscape NeurologyDiener on NeurologyCOMMENTARYTop Studies From European Stroke Organisation Congress 2024 in ReviewHans-Christoph Diener, MD, PhD...
Osteoarthritis Drugs Need Trials With Appropriate Endpoints
Medscape· 3 days agoFor the elusive target of disease-modifying OA drugs (DMOADs), "there have been a lot of...
Lifestyle Changes Still Net Benefits in OA, RA After 2 Years
Medscape· 6 days agoAt the European Alliance of Associations for Rheumatology (EULAR) 2024 Annual Meeting, Carlijn...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 4 days agoWith a safety profile comparable with that seen in adult patients, ixekizumab "met the prespecified...
FDA Approves Adagrasib for KRAS G12C–Mutated CRC
Medscape· 3 days agoThis marks the first approval for a KRAS inhibitor to treat CRC.
Why Don't Migraine Patients Seek Treatment?
Medscape· 5 days agoNearly one in three patients with migraine is reluctant to seek medical help and many blame health care providers, results of a recent survey showed....
Slowing inflammation may boost immunotherapy’s e | Newswise
Newswise· 6 days agoPHILADELPHIA – Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a ...
A New Psychotherapeutic 'Gold Standard' for Chronic Pain?
Medscape· 5 days agoA single course of treatment with emotional awareness and expression therapy (EAET) was associated...
Blood Biomarker Panel May Predict PD Years in Advance
Medscape· 6 days agoA panel of eight blood biomarkers may be able to identify which patients will go on to develop...
In It Together: Doctor and Patient on GLP-1s
Medscape· 4 days agoEarlier this year, Fernandez found a new clinician who suggested he take a glucagon-like peptide 1 (GLP-1) receptor agonist for weight loss. When...